1. Committee for Proprietary Medicinal Products, Virus validation studies: design, contribution and interpretation of studies validating the inactivation and removal of viruses, CPMP/BWP/268/95, European Agency for the Evaluation of Medicinal Products, 1996
2. Committee for Proprietary Medicinal Products, Medicinal products derived form human plasma, CPMP/BWP/269/95, European Agency for the Evaluation of Medicinal Products
3. Committee for Proprietary Medicinal Products, NAT testing of plasma pools, Addendum to CPMP/BWP/269/95, CPMP/BWP/390/97, European Agency for the Evaluation of Medicinal Products, 1998
4. Food and Drug Administration, Center for Biologics Evaluation and Research, Voluntary recall of pooled plasma, solvent detergent treated, FDA, 1999
5. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture;Saldanha;Br J Haematol,1996